0.0575
price down icon42.50%   -0.0425
 
loading
Schlusskurs vom Vortag:
$0.10
Offen:
$0.0676
24-Stunden-Volumen:
413.42K
Relative Volume:
0.35
Marktkapitalisierung:
$697.73K
Einnahmen:
-
Nettoeinkommen (Verlust:
$-48.85M
KGV:
-0.0249
EPS:
-2.31
Netto-Cashflow:
$-46.25M
1W Leistung:
-79.09%
1M Leistung:
-90.09%
6M Leistung:
-99.24%
1J Leistung:
-99.68%
1-Tages-Spanne:
Value
$0.0451
$0.084
1-Wochen-Bereich:
Value
$0.0451
$0.2185
52-Wochen-Spanne:
Value
$0.0451
$18.70

Vincerx Pharma Inc Stock (VINC) Company Profile

Name
Firmenname
Vincerx Pharma Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2025-04-01
Name
Neueste SEC-Einreichungen
Name
VINC's Discussions on Twitter

Vergleichen Sie VINC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VINC
Vincerx Pharma Inc
0.0575 697.73K 0 -48.85M -46.25M -2.31
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-01-14 Eingeleitet H.C. Wainwright Buy
2021-12-23 Eingeleitet Cantor Fitzgerald Overweight
2021-11-01 Eingeleitet SVB Leerink Outperform
2021-09-13 Eingeleitet Laidlaw Buy
2021-08-25 Eingeleitet B. Riley Securities Buy

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

pulisher
Apr 23, 2025

Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister

Apr 22, 2025
pulisher
Apr 21, 2025

Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga

Apr 21, 2025
pulisher
Apr 21, 2025

The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com

Apr 21, 2025
pulisher
Apr 21, 2025

VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India

Apr 21, 2025
pulisher
Apr 17, 2025

Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 17, 2025

Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India

Apr 17, 2025
pulisher
Apr 17, 2025

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma announces plan to delist from Nasdaq - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan

Apr 17, 2025
pulisher
Apr 16, 2025

Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace

Apr 16, 2025
pulisher
Apr 16, 2025

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World

Apr 16, 2025
pulisher
Apr 12, 2025

vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia

Apr 12, 2025
pulisher
Apr 12, 2025

vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India

Apr 12, 2025
pulisher
Apr 11, 2025

Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks

Apr 11, 2025
pulisher
Apr 09, 2025

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com

Apr 09, 2025
pulisher
Apr 09, 2025

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

Apr 09, 2025
pulisher
Apr 09, 2025

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com

Apr 08, 2025
pulisher
Apr 08, 2025

Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Failed Merger Forces Vincerx Pharma to Begin Company Wind-Down: What's Next for Investors? - Stock Titan

Apr 08, 2025
pulisher
Mar 31, 2025

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 28, 2025

Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 25, 2025

Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView

Mar 25, 2025
pulisher
Mar 19, 2025

Such Is The Power Of Vincerx Pharma Inc (NASDAQ: VINC) - Stocks Register

Mar 19, 2025
pulisher
Mar 19, 2025

Vincerx Pharma plans reverse merger with QumulusAI By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

VINC stock touches 52-week low at $0.73 amid sharp annual decline - Investing.com UK

Mar 18, 2025
pulisher
Mar 18, 2025

Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI -March 18, 2025 at 09:40 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Vincerx Pharma plans reverse merger with QumulusAI - Investing.com India

Mar 18, 2025

Finanzdaten der Vincerx Pharma Inc-Aktie (VINC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):